Report copyright - ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · step1 and resume Imatinib Accord at reduced dose of 260 2mg/m. Accelerated phase CML and blast crisis and Ph+ ALL (starting dose 600
Please pass captcha verification before submit form
Please pass captcha verification before submit form